Atopic Dermatitis Treatment Market By Product (Calcineurin Inhibitors, Corticosteroids, Biologic Therapy, Immunosuppressants, and Others), By Route of Administration (Oral, Topical, Injectable), By End-Users (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, and Others), and By Region - Trends, Analysis and Forecast till 2034

Report Code: PMI514823 | Publish Date: March 2024 | No. of Pages: 170

Atopic Dermatitis Treatment Market Companies

  • Novartis
  • Sanofi SA
  • Bayer AG
  • Galderma SA
  • Bristol-Myers Squibb
  • Allergan Plc.
  • Astellas Pharma Inc.
  • Regeneron Pharmaceutical
  • Anacor Pharmaceuticals
  • Meda Pharmaceuticals

Recent News:

  • According to recent research article by PubMed Central, Atopic dermatitis (AD) is a common chronic or chronically relapsing, intensely pruritic inflammatory skin disease. Worldwide, it affects up to 20% of children and 2–8% of adults, who often present a personal or familial history of atopic diathesis. AD point prevalence appears to be increasing in all continents and slightly higher in female than male individuals (0.6–24.3% vs. 0.8–17.6%)